Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ODI Pharma AB's book value per share for the quarter that ended in Mar. 2026 was kr0.10.
During the past 12 months, ODI Pharma AB's average Book Value Per Share Growth Rate was 84.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -66.40% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -54.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of ODI Pharma AB was 31.80% per year. The lowest was -66.40% per year. And the median was -49.95% per year.
ODI Pharma AB's current price is kr2.80. Its book value per share for the quarter that ended in Mar. 2026 was kr0.10. Hence, today's PB Ratio of ODI Pharma AB is 28.57.
During the past 7 years, the highest P/B Ratio of ODI Pharma AB was 225.00. The lowest was 2.94. And the median was 14.56.
ODI Pharma AB (XSAT:ODI) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
ODI Pharma AB Book Value per Share Related Terms
ODI Pharma AB Book Value per Share Historical Data
* Premium members only.
The historical data trend for ODI Pharma AB's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:ODI vs ZTS, UTHR, VTRS: Book Value per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ODI Pharma AB PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where ODI Pharma AB's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ODI Pharma AB (XSAT:ODI) has a Book Value per Share of kr0.10 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on ODI Pharma AB and its competitors.
Is ODI Pharma AB's Book Value per Share too high?
ODI Pharma AB's current Book Value per Share is kr0.10. Overall, ODI Pharma AB has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ODI Pharma AB's Book Value per Share compare to ZTS and UTHR?
ODI Pharma AB's Book Value per Share of kr0.10 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on ODI Pharma AB and its competitors. ODI Pharma AB's current Book Value per Share is kr0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ODI Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, ODI Pharma AB (XSAT:ODI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr9.66, compared to a current price of kr2.80 — trading 71% below its estimated fair value. The current Book Value per Share is kr0.10. ODI Pharma AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For ODI Pharma AB (XSAT:ODI), the current Book Value per Share is kr0.10 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?
Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued.
The current stock price of kr2.80 is trading 71% below its estimated GF Value™ of kr9.66.
GuruFocus considers ODI Pharma AB to be Significantly Undervalued.
Key valuation signals for XSAT:ODI:
Book Value per Share: kr0.10
GF Value™: kr9.66 vs. price of kr2.80 (71% below fair value)
No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ODI has been successfully added to your 
